National Priority Voucher Program
The FDA has announced the first nine companies to participate in its National Priority Voucher program, which aims to promote novel treatments that benefit the health interests of Americans.
Nine medications are on the initial list of program participants, including those that meet a large, unmet need or reduce downstream health care utilization.
Medications that utilize MFN pricing can also be considered for the program.
The Priority Voucher program is a new initiative at the agency to promote novel treatments.
Author summary: FDA announces participants in National Priority Voucher program.
More News
- Westmeath SHC Final: Exciting encounter ends in a draw
- Trump posts AI video of himself in a jet dumping brown liquid on 'No Kings' protests
- Ashton Jeanty Has Made Franchise History
- ‘SNL’ recap: Best moments from Sabrina Carpenter hosting ‘Saturday Night Live’
- Trump posts AI video of himself in a jet dumping brown liquid on 'No Kings' protests